Incretin & Amylin Receptor-Agonist Peptides

Incretin and amylin receptor-agonist peptides are a research-chemical class of synthetic peptide analogs and fragments defined by their molecular targeting of the GLP-1, GIP, glucagon and amylin receptor families. This research peptides Australia category groups reference standard materials that share incretin-axis and amylinomimetic peptide architecture, including mono-, dual- and tri-agonist sequences and structurally related fragment analogs. Every item is an HPLC-verified research-grade analytical reference material supplied strictly for Research Use Only (RUO). Each batch is characterised by reversed-phase HPLC for chromatographic purity and by mass spectrometry for identity confirmation, and ships with a batch-specific Batch Verification Report (BVR). The catalogue spans Retatrutide (10/20/30mg), Cagrilintide (5/10mg), Eloralintide (5/10mg), AOD-9604 (5/10mg) and Adamax, each documented by lot number, molecular weight and purity data. All materials are held for Australian domestic supply. Listings describe peptide chemistry, sequence class and quality-control specifications only; no application, outcome or non-laboratory use is described or implied.